Inaugural Asia Summit on Global Health explores healthcare landscape

30.11.2021

The event attracted more than 21,000 participants. Sustainable development and technological innovation were in focus.

More than 70 speakers, including senior government officials from across the world overseeing health and hygiene, representatives of international organisations, medical research experts, as well as investors and business leaders met up on 24 November at the Hong Kong Convention and Exhibition Centre (HKCEC) in a hybrid format for the inaugural Asia Summit on Global Health (ASGH). This event was co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC). The summit highlighted the strengths of Hong Kong's healthcare industry in the areas of scientific research, investment and financing, as well as the access to business platforms the city provides.

Through 18 thematic sessions, a succession of distinguished speakers discussed the latest scientific research development and investment opportunities in the medical and health industry from the perspectives of healthcare, finance and technology. The summit received an overwhelming response, attracting more than 21,000 onsite and online participants from 46 countries and regions. It also facilitated more than 200 one-to-one matching meetings through matchmaking sessions between investors and project owners, helping to connect different players within the industry and through the InnoHealth showcase and exhibition to encourage business exchange and collaboration among participants.

German exhibitor receives many enquiries
German medical start-up Vibrosonic was delighted with the results. "We are overwhelmed by the vast amount of enquiries received at our booth. Some could be turned into very useful business leads and some as potential investment partners. ASGH has been a successful event and we have benefited much as an exhibitor," exclaimed Dominik Kaltenbacher, founder and CEO of Vibrosonic, who was also a guest speaker at ASGH. Vibrosonic, manufacturer of non-surgical and invisible high-quality hearing contact lenses for the hearing-impaired, sees Hong Kong as a its natural choice for expansion.

“Hong Kong’s unique medical innovation ecosystem combined with its status as a financial hub and its proximity to Guangdong’s advanced and cost-effective manufacturing capabilities put Hong Kong in an ideal position to becoming a world-class health technology hub and biotechnology financing centre”, said Winsome Chan, director, Germany and Central Europe at HKTDC. Hong Kong can facilitate financing for healthcare companies including but not limited to the DACH region, as well as the city’s advantages as a base for strategic biomedical research in the region, Chan added.

The panel discussion “Healthcare in China: Deciphering the Dual Circulation Opportunities” shed light on the dual circulation strategy’s impact on the healthcare industry in Mainland China. Claudia Süessmuth Dyckerhoff, board member of Hoffmann-La Roche said “Access to care can be secured not only by pushing for very low pharmaceutical and diagnostic prices, but also by more innovative insurance schemes. I think the two worlds have to come together to make innovation more accessible and obviously more affordable.”

All conference sessions will be available for on-demand replay until 23 December.

https://www.asiasummitglobalhealth.com